Aphria Inc. (TSX: APH) (OTC: APHQF) announced this morning that the company has received a license amendment from Health Canada that will provide Aphria with an additional 200,000 square feet of cannabis grow space, which will allow the company to complete Part III expansion of its facility in Leamington, Ontario.
The expansion of the Leamington facility triples the Aphria’s production capacity of medical grade cannabis from 9,000 kg annually to 30,000 kg annually.
When Aphria completely expands the facility in Ontario, the company will have over 1,000,000 sq. ft. of production space to grow cannabis at their disposal. Along with their partnerships with Broken Coast Cannabis and Double Diamond Farms, Aphria is anticipating their production capacity to become over 230,00 kg a year.
Aphria is ramping up production ahead of the expected legalization of recreational cannabis in Canada this year, as well, as to expand to international markets.
You may be interested
Canopy River Begins Trading on the Toronto Stock Exchange (TSX)Editor - September 21, 2018
Yesterday, Canopy Rivers Inc. (TSXV:RIV) announced that their company has began trading on the TSX Venture Exchange under the ticker symbol RIV. The company works in conjunction with…
Aurora Cannabis in Discussions with Coca-Cola to Produce CBD Infused BeveragesEditor - September 20, 2018
In a press release this week, Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF) confirmed that it has entered into the beginning stages of negotiations with beverage conglomerate Coca-Cola to…
Australian CBD Company Elixinol Begins Trading on OTCQXEditor - September 19, 2018
Yesterday, international hemp-derived CBD company Elixinol (ASX: EXL) began trading on the OTCQX, a U.S. based stock market exchange, under the ticker symbol ELLXF. The company is…